Scilex Holding Co (SCLX)
0.9054
+0.04
(+4.07%)
USD |
NASDAQ |
May 17, 16:00
0.938
+0.03
(+3.60%)
After-Hours: 20:00
Scilex Total Liabilities (Quarterly): 281.03M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 281.03M |
| December 31, 2023 | 274.25M |
| September 30, 2023 | 243.20M |
| June 30, 2023 | 116.05M |
| Date | Value |
|---|---|
| March 31, 2023 | 74.98M |
| December 31, 2022 | 50.29M |
| September 30, 2022 | 318.17M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
50.29M
Minimum
Dec 2022
318.17M
Maximum
Sep 2022
193.99M
Average
243.20M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| Sorrento Therapeutics Inc | 654.65M |
| Adial Pharmaceuticals Inc | 0.6531M |
| Precision BioSciences Inc | 147.54M |
| Humacyte Inc | 135.31M |
| Perspective Therapeutics Inc | 48.40M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 91.24M |
| Shareholders Equity (Quarterly) | -189.79M |
| Debt to Equity Ratio | -0.5756 |
| Current Ratio | 0.1493 |
| Net Debt Paydown Yield | -12.95% |